Review of Clinically Relevant Drug Interactions with Next Generation Hepatitis C Direct-acting Antiviral Agents

In this review, we examine the pharmacokinetics and clinically relevant drug interactions of the newer generation direct-acting antivirals (DAAs) for the treatment of chronic hepatitis C, specifically sofosbuvir/velpatasvir (Epclusa(®)), sofosbuvir/velpatasvir/voxilaprevir (Vosevi(®)), glecaprevir/p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Jenny, Wright, Robert C., Partovi, Nilu, Yoshida, Eric M., Hussaini, Trana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562806/
https://www.ncbi.nlm.nih.gov/pubmed/33083256
http://dx.doi.org/10.14218/JCTH.2020.00034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562806/
https://www.ncbi.nlm.nih.gov/pubmed/33083256
http://dx.doi.org/10.14218/JCTH.2020.00034

Ejemplares similares